169448-17-3 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-tert-butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate is used as a building block for the synthesis of various pharmaceuticals and fine chemicals. Its unique structure allows it to be a key component in the creation of complex organic molecules for medicinal applications.
Used as a Chiral Auxiliary in Organic Synthesis:
In the field of organic synthesis, (S)-tert-butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate is utilized as a chiral auxiliary. It is employed for its ability to induce asymmetric induction, which is crucial for the production of enantiomerically pure compounds, often necessary for biological activity and selectivity in drug development.
Used in Medicinal Chemistry for Drug Development:
(S)-tert-butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate is applied in medicinal chemistry for the development of new drugs and therapeutic agents. Its potential in this area stems from its capacity to influence the stereochemistry of molecules, which is vital for the efficacy and selectivity of pharmaceutical compounds.
Used in the Development of Asymmetric Catalysis:
(S)-tert-butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate may also be used in the development of asymmetric catalysis techniques, where its chiral properties can be leveraged to produce enantioselective reactions, leading to the synthesis of biologically active molecules with a single enantiomer.
Used in Research and Development of Novel Chemical Entities:
In the research and development sector, (S)-tert-butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate serves as a valuable tool for probing new chemical space and developing novel chemical entities with potential therapeutic benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 169448-17-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,4,4 and 8 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 169448-17:
(8*1)+(7*6)+(6*9)+(5*4)+(4*4)+(3*8)+(2*1)+(1*7)=173
173 % 10 = 3
So 169448-17-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H22N2O3/c1-11(2,3)16-10(15)13-6-5-12-8-9(13)4-7-14/h9,12,14H,4-8H2,1-3H3/t9-/m0/s1
169448-17-3Relevant academic research and scientific papers
CYCLIC (AZA)INDOLIZINECARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
-
, (2011/02/24)
The present invention relates to cyclic indolizinecarboxamides and azaindolizinecarboxamides of the formulae Ia and Ib, (Ia) (Ib) wherein R, Ra, R10, R20, R30, R40, Y, n, p and q have the meanings ind
Prenyl transferase inhibitors
-
, (2008/06/13)
A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by the four following formulas Each of the R groups is defined in the disclosure.
Thioproline-containing inhibitors of farnesyl protein transferase
-
, (2008/06/13)
Inhibition of farnesyl transferase, which is an enzyme involved in ras oncogene expression, is effected b STR1 its enantiomers, diastereomers, and pharmaceutically acceptable salts and solvates thereof.
Inhibitors of farnesyl-protein transferase
-
, (2008/06/13)
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras. The compounds of formula A are representative of the compounds of the present invention: STR1
